Home/Pipeline/Automatic Subnuclei Segmentation

Automatic Subnuclei Segmentation

Enhanced targeting for Deep Brain Stimulation (DBS)

DevelopmentIntegration for OR use (w/ Philips)

Key Facts

Indication
Enhanced targeting for Deep Brain Stimulation (DBS)
Phase
Development
Status
Integration for OR use (w/ Philips)
Company

About ClearPoint Neuro

ClearPoint Neuro's mission is to improve and restore quality of life by enabling therapies for complex neurological disorders with pinpoint accuracy. The company has established itself as an industry leader by supporting over 7,000 procedures and partnering with more than 60 biologics and drug delivery companies. Its integrated platform combines real-time MRI guidance with specialized hardware and software, facilitating a seamless transition from pre-clinical research to clinical trials and commercial procedures. ClearPoint focuses exclusively on the neuro space, providing critical infrastructure for the advancing fields of gene therapy, cell therapy, and targeted drug delivery to the central nervous system.

View full company profile

Therapeutic Areas